Market Executive Summary
Due to the COVID-19 pandemic, the global T-Cell Therapy market size was US$ 2.60 billion in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of 35% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, CAR T Cell Therapy accounting for % of the T-Cell Therapy global market in 2022, is projected to value US$ million by 2029, growing at a revised ?GR from 2023 to 2029. While Hospitals segment is altered to an ?GR throughout this forecast period.
The global key companies of T-Cell Therapy include Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG, AbbVie Inc., Adaptimmune Therapeutics PLC, Bluebird Bio, TCR2 Therapeutics, Inc. and Pfizer Inc., etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States T-Cell Therapy market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2029, trailing a CAGR of % through the analysis period. As for the Europe T-Cell Therapy landscape, Germany is projected to reach US$ million by 2029. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global T-Cell Therapy market. The analysts authoring the report have closely studied key strategies adopted by top players of the global T-Cell Therapy market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global T-Cell Therapy market. Readers of the report can become informed about current and future trends of the global T-Cell Therapy market and how they will impact market growth during the forecast period.
By Company
Gilead Sciences, Inc.
Sorrento Therapeutics
Fate Therapeutics Inc.
Novartis International AG
AbbVie Inc.
Adaptimmune Therapeutics PLC
Bluebird Bio
TCR2 Therapeutics, Inc.
Pfizer Inc.
DiaCarta, Inc.
Segment by Type
CAR T Cell Therapy
TCR Therapy
TIL Therapy
Segment by Application
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of T-Cell Therapy in global and regional level.
Chapter 3: Detailed analysis of T-Cell Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, T-Cell Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion
Related Report:
Global Advanced Cell Therapies Market Analysis, Share, Opportunities, Growth Trends and Forecast 2023-2030
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CAR T Cell Therapy
1.2.3 TCR Therapy
1.2.4 TIL Therapy
1.3 Market by Application
1.3.1 Global T-Cell Therapy Market Growth Rate by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global T-Cell Therapy Market Size (2018-2029)
2.2 T-Cell Therapy Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2029
2.3 Global T-Cell Therapy Market Size by Region (2018-2023)
2.4 Global T-Cell Therapy Market Size Forecast by Region (2024-2029)
2.5 Global Top 10 T-Cell Therapy Countries Ranking by Market Size
3 T-Cell Therapy Competitive by Company
3.1 Global T-Cell Therapy Revenue by Players
3.1.1 Global T-Cell Therapy Revenue by Players (2018-2023)
3.1.2 Global T-Cell Therapy Market Share by Players (2018-2023)
3.2 Global T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by T-Cell Therapy Revenue
3.4 Global T-Cell Therapy Market Concentration Ratio
3.4.1 Global T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Therapy Revenue in 2022
3.5 Global Key Players of T-Cell Therapy Head office and Area Served
3.6 Global Key Players of T-Cell Therapy, Product and Application
3.7 Global Key Players of T-Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global T-Cell Therapy Breakdown Data by Type
4.1 Global T-Cell Therapy Historic Revenue by Type (2018-2023)
4.2 Global T-Cell Therapy Forecasted Revenue by Type (2024-2029)
5 Global T-Cell Therapy Breakdown Data by Application
5.1 Global T-Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global T-Cell Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America T-Cell Therapy Revenue by Company (2021-2023)
6.2 North America T-Cell Therapy Revenue by Type (2018-2029)
6.3 North America T-Cell Therapy Revenue by Application (2018-2029)
6.4 North America T-Cell Therapy Revenue by Country (2018-2029)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe T-Cell Therapy Revenue by Company (2021-2023)
7.2 Europe T-Cell Therapy Revenue by Type (2018-2029)
7.3 Europe T-Cell Therapy Revenue by Application (2018-2029)
7.4 Europe T-Cell Therapy Revenue by Country (2018-2029)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific T-Cell Therapy Revenue by Company (2021-2023)
8.2 Asia Pacific T-Cell Therapy Revenue by Type (2018-2029)
8.3 Asia Pacific T-Cell Therapy Revenue by Application (2018-2029)
8.4 Asia Pacific T-Cell Therapy Revenue by Region (2018-2029)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America T-Cell Therapy Revenue by Company (2021-2023)
9.2 Latin America T-Cell Therapy Revenue by Type (2018-2029)
9.3 Latin America T-Cell Therapy Revenue by Application (2018-2029)
9.4 Latin America T-Cell Therapy Revenue by Country (2018-2029)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa T-Cell Therapy Revenue by Company (2021-2023)
10.2 Middle East and Africa T-Cell Therapy Revenue by Type (2018-2029)
10.3 Middle East and Africa T-Cell Therapy Revenue by Application (2018-2029)
10.4 Middle East and Africa T-Cell Therapy Revenue by Country (2018-2029)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Details
11.1.2 Gilead Sciences, Inc. Business Overview
11.1.3 Gilead Sciences, Inc. T-Cell Therapy Products and Services
11.1.4 Gilead Sciences, Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023)
11.1.5 Gilead Sciences, Inc. T-Cell Therapy SWOT Analysis
11.1.6 Gilead Sciences, Inc. Recent Development
11.2 Sorrento Therapeutics
11.2.1 Sorrento Therapeutics Company Details
11.2.2 Sorrento Therapeutics Business Overview
11.2.3 Sorrento Therapeutics T-Cell Therapy Products and Services
11.2.4 Sorrento Therapeutics T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023)
11.2.5 Sorrento Therapeutics T-Cell Therapy SWOT Analysis
11.2.6 Sorrento Therapeutics Recent Development
11.3 Fate Therapeutics Inc.
11.3.1 Fate Therapeutics Inc. Company Details
11.3.2 Fate Therapeutics Inc. Business Overview
11.3.3 Fate Therapeutics Inc. T-Cell Therapy Products and Services
11.3.4 Fate Therapeutics Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023)
11.3.5 Fate Therapeutics Inc. T-Cell Therapy SWOT Analysis
11.3.6 Fate Therapeutics Inc. Recent Development
11.4 Novartis International AG
11.4.1 Novartis International AG Company Details
11.4.2 Novartis International AG Business Overview
11.4.3 Novartis International AG T-Cell Therapy Products and Services
11.4.4 Novartis International AG T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023)
11.4.5 Novartis International AG T-Cell Therapy SWOT Analysis
11.4.6 Novartis International AG Recent Development
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Details
11.5.2 AbbVie Inc. Business Overview
11.5.3 AbbVie Inc. T-Cell Therapy Products and Services
11.5.4 AbbVie Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023)
11.5.5 AbbVie Inc. T-Cell Therapy SWOT Analysis
11.5.6 AbbVie Inc. Recent Development
11.6 Adaptimmune Therapeutics PLC
11.6.1 Adaptimmune Therapeutics PLC Company Details
11.6.2 Adaptimmune Therapeutics PLC Business Overview
11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Products and Services
11.6.4 Adaptimmune Therapeutics PLC T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023)
11.6.5 Adaptimmune Therapeutics PLC T-Cell Therapy SWOT Analysis
11.6.6 Adaptimmune Therapeutics PLC Recent Development
11.7 Bluebird Bio
11.7.1 Bluebird Bio Company Details
11.7.2 Bluebird Bio Business Overview
11.7.3 Bluebird Bio T-Cell Therapy Products and Services
11.7.4 Bluebird Bio T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023)
11.7.5 Bluebird Bio T-Cell Therapy SWOT Analysis
11.7.6 Bluebird Bio Recent Development
11.8 TCR2 Therapeutics, Inc.
11.8.1 TCR2 Therapeutics, Inc. Company Details
11.8.2 TCR2 Therapeutics, Inc. Business Overview
11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Products and Services
11.8.4 TCR2 Therapeutics, Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023)
11.8.5 TCR2 Therapeutics, Inc. T-Cell Therapy SWOT Analysis
11.8.6 TCR2 Therapeutics, Inc. Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. T-Cell Therapy Products and Services
11.9.4 Pfizer Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023)
11.9.5 Pfizer Inc. T-Cell Therapy SWOT Analysis
11.9.6 Pfizer Inc. Recent Development
11.10 DiaCarta, Inc.
11.10.1 DiaCarta, Inc. Company Details
11.10.2 DiaCarta, Inc. Business Overview
11.10.3 DiaCarta, Inc. T-Cell Therapy Products and Services
11.10.4 DiaCarta, Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023)
11.10.5 DiaCarta, Inc. T-Cell Therapy SWOT Analysis
11.10.6 DiaCarta, Inc. Recent Development
12 T-Cell Therapy Market Dynamics
12.1 T-Cell Therapy Industry Trends
12.2 T-Cell Therapy Market Drivers
12.3 T-Cell Therapy Market Challenges
12.4 T-Cell Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures
List of Tables
Table 1. Global T-Cell Therapy Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of CAR T Cell Therapy
Table 3. Key Players of TCR Therapy
Table 4. Key Players of TIL Therapy
Table 5. Global T-Cell Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global T-Cell Therapy Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
Table 7. Global T-Cell Therapy Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global T-Cell Therapy Revenue Forecast by Region (2024-2029) & (US$ Million)
Table 9. Global T-Cell Therapy Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Table 10. Global T-Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 11. Global T-Cell Therapy Market Share by Players (2018-2023)
Table 12. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Therapy as of 2022)
Table 13. Ranking of Global Top T-Cell Therapy Companies by Revenue (US$ Million) in 2022
Table 14. Global 5 Largest Players Market Share by T-Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 15. Global Key Players of T-Cell Therapy, Headquarters and Area Served
Table 16. Global Key Players of T-Cell Therapy, Product and Application
Table 17. Global Key Players of T-Cell Therapy, Date of Enter into This Industry
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 20. Global T-Cell Therapy Revenue Market Share by Type (2018-2023)
Table 21. Global T-Cell Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 22. Global T-Cell Therapy Revenue Market Share by Type (2024-2029)
Table 23. Global T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 24. Global T-Cell Therapy Revenue Market Share by Application (2018-2023)
Table 25. Global T-Cell Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 26. Global T-Cell Therapy Revenue Market Share by Application (2024-2029)
Table 27. North America T-Cell Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 28. North America T-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 29. North America T-Cell Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 30. North America T-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. North America T-Cell Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 32. North America T-Cell Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America T-Cell Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 34. North America T-Cell Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 35. Europe T-Cell Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 36. Europe T-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 37. Europe T-Cell Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 38. Europe T-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 39. Europe T-Cell Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 40. Europe T-Cell Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Europe T-Cell Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 42. Europe T-Cell Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 43. Asia Pacific T-Cell Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 44. Asia Pacific T-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 45. Asia Pacific T-Cell Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 46. Asia Pacific T-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 47. Asia Pacific T-Cell Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 48. Asia-Pacific T-Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 49. Asia Pacific T-Cell Therapy Revenue by Region (2018-2023) & (US$ Million)
Table 50. Asia Pacific T-Cell Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 51. Latin America T-Cell Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 52. Latin America T-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 53. Latin America T-Cell Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 54. Latin America T-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 55. Latin America T-Cell Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 56. Latin America T-Cell Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 57. Latin America T-Cell Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 58. Latin America T-Cell Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 59. Middle East and Africa T-Cell Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 60. Middle East and Africa T-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 61. Middle East and Africa T-Cell Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 62. Middle East and Africa T-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 63. Middle East and Africa T-Cell Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 64. Middle East and Africa T-Cell Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 65. Middle East and Africa T-Cell Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 66. Middle East and Africa T-Cell Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 67. Gilead Sciences, Inc. Company Details
Table 68. Gilead Sciences, Inc. Business Overview
Table 69. Gilead Sciences, Inc. T-Cell Therapy Product and Services
Table 70. Gilead Sciences, Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 71. Gilead Sciences, Inc. T-Cell Therapy SWOT Analysis
Table 72. Gilead Sciences, Inc. Recent Development
Table 73. Sorrento Therapeutics Company Details
Table 74. Sorrento Therapeutics Business Overview
Table 75. Sorrento Therapeutics T-Cell Therapy Product and Services
Table 76. Sorrento Therapeutics T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 77. Sorrento Therapeutics T-Cell Therapy SWOT Analysis
Table 78. Sorrento Therapeutics Recent Development
Table 79. Fate Therapeutics Inc. Company Details
Table 80. Fate Therapeutics Inc. Business Overview
Table 81. Fate Therapeutics Inc. T-Cell Therapy Product and Services
Table 82. Fate Therapeutics Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 83. Fate Therapeutics Inc. T-Cell Therapy SWOT Analysis
Table 84. Fate Therapeutics Inc. Recent Development
Table 85. Novartis International AG Company Details
Table 86. Novartis International AG Business Overview
Table 87. Novartis International AG T-Cell Therapy Product and Services
Table 88. Novartis International AG T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 89. Novartis International AG T-Cell Therapy SWOT Analysis
Table 90. Novartis International AG Recent Development
Table 91. AbbVie Inc. Company Details
Table 92. AbbVie Inc. Business Overview
Table 93. AbbVie Inc. T-Cell Therapy Product and Services
Table 94. AbbVie Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 95. AbbVie Inc. T-Cell Therapy SWOT Analysis
Table 96. AbbVie Inc. Recent Development
Table 97. Adaptimmune Therapeutics PLC Company Details
Table 98. Adaptimmune Therapeutics PLC Business Overview
Table 99. Adaptimmune Therapeutics PLC T-Cell Therapy Product and Services
Table 100. Adaptimmune Therapeutics PLC T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 101. Adaptimmune Therapeutics PLC T-Cell Therapy SWOT Analysis
Table 102. Adaptimmune Therapeutics PLC Recent Development
Table 103. Bluebird Bio Company Details
Table 104. Bluebird Bio Business Overview
Table 105. Bluebird Bio T-Cell Therapy Product and Services
Table 106. Bluebird Bio T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 107. Bluebird Bio T-Cell Therapy SWOT Analysis
Table 108. Bluebird Bio Recent Development
Table 109. TCR2 Therapeutics, Inc. Company Details
Table 110. TCR2 Therapeutics, Inc. Business Overview
Table 111. TCR2 Therapeutics, Inc. T-Cell Therapy Product and Services
Table 112. TCR2 Therapeutics, Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 113. TCR2 Therapeutics, Inc. T-Cell Therapy SWOT Analysis
Table 114. TCR2 Therapeutics, Inc. Recent Development
Table 115. Pfizer Inc. Company Details
Table 116. Pfizer Inc. Business Overview
Table 117. Pfizer Inc. T-Cell Therapy Product and Services
Table 118. Pfizer Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 119. Pfizer Inc. T-Cell Therapy SWOT Analysis
Table 120. Pfizer Inc. Recent Development
Table 121. DiaCarta, Inc. Company Details
Table 122. DiaCarta, Inc. Business Overview
Table 123. DiaCarta, Inc. T-Cell Therapy Product and Services
Table 124. DiaCarta, Inc. T-Cell Therapy Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 125. DiaCarta, Inc. T-Cell Therapy SWOT Analysis
Table 126. DiaCarta, Inc. Recent Development
Table 127. T-Cell Therapy Market Trends
Table 128. T-Cell Therapy Market Drivers
Table 129. T-Cell Therapy Market Challenges
Table 130. T-Cell Therapy Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. T-Cell Therapy Product Picture
Figure 2. Global T-Cell Therapy Market Size by Type (US$ Million): 2018 VS 2022 VS 2029
Figure 3. Global T-Cell Therapy Market Share by Type: 2022 VS 2029
Figure 4. CAR T Cell Therapy Features
Figure 5. TCR Therapy Features
Figure 6. TIL Therapy Features
Figure 7. Global T-Cell Therapy Market Size by Application (US$ Million): 2018 VS 2022 VS 2029
Figure 8. Global T-Cell Therapy Market Share by Application: 2022 VS 2029
Figure 9. Hospitals
Figure 10. Clinics & Ambulatory Centers
Figure 11. Cancer Research Institutes
Figure 12. Others
Figure 13. T-Cell Therapy Report Years Considered
Figure 14. Global T-Cell Therapy Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global T-Cell Therapy Market Size 2018-2029 (US$ Million)
Figure 16. Global T-Cell Therapy Market Size Market Share by Region: 2022 VS 2029
Figure 17. Global T-Cell Therapy Revenue Market Share by Region in 2018 VS 2022
Figure 18. Global T-Cell Therapy Revenue Market Share Forecast by Region (2024-2029)
Figure 19. Global Top 10 T-Cell Therapy Countries Ranking by Market Size (US$ Million) in 2022
Figure 20. Global T-Cell Therapy Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Figure 21. Global T-Cell Therapy Market Share by Players in 2022
Figure 22. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Therapy as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by T-Cell Therapy Revenue in 2022
Figure 24. North America T-Cell Therapy Revenue Market Share by Company in 2022
Figure 25. North America T-Cell Therapy Revenue Market Share by Type (2018-2029)
Figure 26. North America T-Cell Therapy Revenue Market Share by Application (2018-2029)
Figure 27. North America T-Cell Therapy Revenue Share by Country (2018-2029)
Figure 28. United States T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 29. Canada T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 30. Europe T-Cell Therapy Revenue Market Share by Company in 2022
Figure 31. Europe T-Cell Therapy Revenue Market Share by Type (2018-2029)
Figure 32. Europe T-Cell Therapy Revenue Market Share by Application (2018-2029)
Figure 33. Europe T-Cell Therapy Revenue Share by Country (2018-2029)
Figure 34. Germany T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 35. France T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 36. U.K. T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 37. Italy T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 38. Russia T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 39. Asia Pacific T-Cell Therapy Revenue Market Share by Company in 2022
Figure 40. Asia Pacific T-Cell Therapy Revenue Market Share by Type (2018-2029)
Figure 41. Asia Pacific T-Cell Therapy Revenue Market Share by Application (2018-2029)
Figure 42. Asia Pacific T-Cell Therapy Revenue Share by Region (2018-2029)
Figure 43. China T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 44. Japan T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 45. South Korea T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 46. India T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 47. Australia T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 48. China Taiwan T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 49. Indonesia T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 50. Thailand T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 51. Malaysia T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 52. Latin America T-Cell Therapy Revenue Market Share by Company in 2022
Figure 53. Latin America T-Cell Therapy Revenue Market Share by Type (2018-2029)
Figure 54. Latin America T-Cell Therapy Revenue Market Share by Application (2018-2029)
Figure 55. Latin America T-Cell Therapy Revenue Share by Country (2018-2029)
Figure 56. Mexico T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 57. Brazil T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 58. Argentina T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 59. Middle East and Africa T-Cell Therapy Revenue Market Share by Company in 2022
Figure 60. Middle East and Africa T-Cell Therapy Revenue Market Share by Type (2018-2029)
Figure 61. Middle East and Africa T-Cell Therapy Revenue Market Share by Application (2018-2029)
Figure 62. Middle East and Africa T-Cell Therapy Revenue Share by Country (2018-2029)
Figure 63. Turkey T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 64. Saudi Arabia T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 65. UAE T-Cell Therapy Revenue (2018-2029) & (US$ Million)
Figure 66. Gilead Sciences, Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 67. Sorrento Therapeutics Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 68. Fate Therapeutics Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 69. Novartis International AG Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 70. AbbVie Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 71. Adaptimmune Therapeutics PLC Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 72. Bluebird Bio Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 73. TCR2 Therapeutics, Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 74. Pfizer Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 75. DiaCarta, Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
